ANIX News and Press, Anixa Biosciences Inc. From 01/23/20

Home DNA testing services provider 23andMe ( DNA ) plans to terminate 100 people, 14% of its workforce, in response to weakening sales. Most of the cuts will affect operations teams that were focused on growth and scaling efforts. More news on: 23andMe, Anixa Biosciences, Inc., Guardant ...

SAN JOSE, Calif. , Jan. 6, 2020 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that data from studies utilizing Cchek™, the company's artificial intel...

SAN JOSE, Calif. , Dec. 23, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that its chief executive officer, Dr. Amit Kumar , will present at the Biote...

Anixa Biosciences (NASDAQ: ANIX ) has commercially launched Cchek Prostate Cancer Confirmation test (Cchek PCC), the first test developed with the Cchek artificial intelligence driven, flow cytometry based, liquid biopsy technology platform. More news on: Anixa Biosciences, Inc., He...

SAN JOSE, Calif. , Dec. 16, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced the commercial launch of its Cchek™ Prostate Cancer Confirmation test ...

SAN JOSE, Calif. , Dec. 13, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that it will hold a conference call on December 17, 2019 at 1:30 p.m. Pac...

Gainers:  LMP Automotive (NASDAQ: LMPX ) +95% . More news on: LMP Automotive Holdings, Inc., Sarepta Therapeutics, Inc., Cohen & Company Inc., Stocks on the move, Read more ...

SAN JOSE, Calif. , Dec. 13, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced an update regarding the chimeric antigen receptor T-cell (CAR-T) technology it is ...

Noteworthy events during the week of December 8 - 14 for healthcare investors. More news on: Roche Holding AG, Athenex, Inc., Anixa Biosciences, Inc., Healthcare stocks news, , Read more ...

SAN JOSE, Calif. , Dec. 2, 2019 /PRNewswire/ --  Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cancer, today announced that data from its ongoing studies utilizing Cchek™, its artificial int...